Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of gabapentin for diabetic peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Neurontin) (gabapentin)

Snippet

Sponsor: Depomed | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED